Published in Br J Cancer on December 16, 2008
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest (2015) 1.92
Inflammation: a driving force speeds cancer metastasis. Cell Cycle (2009) 1.78
Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem (2011) 1.70
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer (2013) 1.27
STAT3 and epithelial-mesenchymal transitions in carcinomas. JAKSTAT (2014) 1.24
IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene (2011) 1.21
Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene (2013) 1.16
Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. J Oncol (2009) 1.12
Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One (2011) 1.08
Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3. World J Gastroenterol (2011) 1.06
Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition. Front Oncol (2014) 1.04
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) (2010) 1.03
Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Oncogene (2015) 1.03
IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PLoS One (2011) 1.02
Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden. Front Oncol (2014) 0.98
Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov (2016) 0.98
JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Neuro Oncol (2014) 0.97
EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells? PLoS One (2012) 0.95
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One (2014) 0.95
Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1. Mol Pharmacol (2013) 0.94
Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model. J Transl Med (2013) 0.94
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer. Br J Cancer (2013) 0.93
Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. PLoS One (2014) 0.93
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer (2014) 0.91
DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies. Am J Hum Genet (2013) 0.90
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium. Reprod Biol Endocrinol (2010) 0.90
Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. J Cancer (2014) 0.90
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep (2015) 0.88
Induction of murine macrophage M2 polarization by cigarette smoke extract via the JAK2/STAT3 pathway. PLoS One (2014) 0.88
Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. J Oncol (2012) 0.88
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy. Cancers (Basel) (2014) 0.87
Janus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population. PLoS One (2013) 0.86
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth. Mol Cancer Ther (2015) 0.86
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women. Oncotarget (2015) 0.86
An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findings. Curr Genomics (2009) 0.85
Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Mol Cancer (2011) 0.85
The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Cell Adh Migr (2013) 0.84
Immune biomarkers of anti-EGFR monoclonal antibody therapy. Ann Oncol (2014) 0.84
Effects of bevacizumab in mouse model of endometrial cancer: Defining the molecular basis for resistance. Oncol Rep (2011) 0.84
Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling. Oncotarget (2016) 0.83
The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration. J Biol Chem (2012) 0.83
MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells. Cancer Res (2015) 0.83
Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells. Oncotarget (2015) 0.82
Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments. Biochemistry (2011) 0.82
Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface. Jpn J Ophthalmol (2011) 0.82
Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1. Leukemia (2015) 0.82
BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development. Am J Cancer Res (2013) 0.81
Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression. PLoS One (2013) 0.81
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms. Mediators Inflamm (2015) 0.81
Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer. J Ovarian Res (2010) 0.80
Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling. Cell Mol Gastroenterol Hepatol (2015) 0.80
Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer. PLoS One (2015) 0.79
STAT1-mediated down-regulation of Bcl-2 expression is involved in IFN-γ/TNF-α-induced apoptosis in NIT-1 cells. PLoS One (2015) 0.79
STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer. Oncol Rep (2016) 0.78
Ovarian epithelial-stromal interactions: role of interleukins 1 and 6. Obstet Gynecol Int (2011) 0.78
Separation and Characterization of Epithelial and Mesenchymal-like Murine Mammary Tumor Cells Reveals Epithelial Cell Differentiation Plasticity and Enhanced Tumorigenicity of Epithelial-enriched Tumor Cells. Cancer Microenviron (2012) 0.78
Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer. Mol Med Rep (2015) 0.77
miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer. J Cancer Sci Ther (2016) 0.77
Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women. J Transl Med (2012) 0.77
Voting-based cancer module identification by combining topological and data-driven properties. PLoS One (2013) 0.76
Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway. Cancer Res Treat (2016) 0.76
EMT and inflammation: inseparable actors of cancer progression. Mol Oncol (2017) 0.75
A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models. PLoS One (2016) 0.75
Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non-small cell lung cancer. Onco Targets Ther (2017) 0.75
Interleukin‑6 induces epithelial‑mesenchymal transition in human intrahepatic biliary epithelial cells. Mol Med Rep (2015) 0.75
Interleukin-6 from Ovarian Mesenchymal Stem Cells Promotes Proliferation, Sphere and Colony Formation and Tumorigenesis of an Ovarian Cancer Cell Line SKOV3. J Cancer (2016) 0.75
Requirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling Pathways. PLoS One (2016) 0.75
Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget (2016) 0.75
Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. Oncotarget (2016) 0.75
B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway. Am J Transl Res (2017) 0.75
ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways. Oncotarget (2017) 0.75
Screening of potentially crucial genes and regulatory factors involved in epithelial ovarian cancer using microarray analysis. Oncol Lett (2017) 0.75
Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol (2002) 15.33
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest (2007) 5.17
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res (2007) 3.53
Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J (1999) 3.19
Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis (1995) 2.62
Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res (2004) 2.24
Border-cell migration: the race is on. Nat Rev Mol Cell Biol (2003) 2.09
Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila. Cell (2001) 2.05
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol (2007) 1.97
Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol (2000) 1.83
Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res (2004) 1.71
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer (2007) 1.63
Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol (2006) 1.59
Stat3 Controls Cell Movements during Zebrafish Gastrulation. Dev Cell (2002) 1.57
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer (2006) 1.55
Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res (2001) 1.52
BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis (2007) 1.45
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia (2007) 1.45
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin Cancer Res (2005) 1.42
SnapShot: EGFR signaling pathway. Cell (2007) 1.35
The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGF-stimulated cell migration. J Cell Sci (2007) 1.34
Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res (2007) 1.33
Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol (2004) 1.30
Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs (2007) 1.29
Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis (2002) 1.27
Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol (2003) 1.24
Zinc transporter LIV-1: a link between cellular development and cancer progression. Trends Endocrinol Metab (2004) 1.21
Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer (2007) 1.20
Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. J Histochem Cytochem (2002) 1.15
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer (2005) 1.13
STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol (1985) (2007) 1.08
Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling. IUBMB Life (2004) 1.07
Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. Neoplasia (2005) 1.06
Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis. Cells Tissues Organs (2007) 1.04
Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas. Cytokine (2002) 1.04
Differential expression and activation of Stat3 during mouse embryo implantation and decidualization. Mol Reprod Dev (2004) 1.01
Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin. Int J Biochem Cell Biol (2008) 0.99
Involvement of JAK2 upstream of the PI 3-kinase in cell-cell adhesion regulation by gastrin. Exp Cell Res (2004) 0.98
Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury. Mol Vis (2004) 0.98
Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. Cancer Res (2007) 0.98
Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases. Int J Cancer (2006) 0.96
Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer. Oncology (Williston Park) (2005) 0.94
Menstrual effluent induces epithelial-mesenchymal transitions in mesothelial cells. Hum Reprod (2004) 0.81
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J (1999) 2.79
Search and discovery strategies for biotechnology: the paradigm shift. Microbiol Mol Biol Rev (2000) 2.64
Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood (2001) 2.61
The Use of Intrathecal Heparin in Conjunction with Streptomycin in the Treatment of Tuberculous Meningitis: Preliminary Report. J Clin Pathol (1948) 2.40
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology (2011) 2.24
The skeletal metastatic complications of renal cell carcinoma. Int J Oncol (2001) 2.12
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene (2007) 2.12
Prospective assessment of outcomes following disposable arthroscopy of the temporomandibular joint. Br J Oral Maxillofac Surg (2013) 2.09
Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol (1985) (2000) 1.87
Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol (1997) 1.82
Relationship between fatty-acid and phenol synthesis in Aspergillus fumigatus. Eur J Biochem (1974) 1.80
Haemophilus somnus: Bovine Reproductive and Respiratory Disease. Can Vet J (1986) 1.64
Temperature-sensitive cell division component in a mutant of Salmonella typhimurium. J Gen Microbiol (1971) 1.63
Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am J Physiol Endocrinol Metab (2000) 1.62
Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry (2008) 1.60
Epithelial neoplasms of the vermiform appendix (exclusive of carcinoid). I. Adenocarcinoma of the appendix. Cancer (1976) 1.58
The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature (1984) 1.58
Isolation of a previously undescribed rickettsia from an aborted bovine fetus. J Clin Microbiol (1990) 1.58
The prevalence of posttraumatic stress disorder and its clinical significance among Southeast Asian refugees. Am J Psychiatry (1990) 1.55
Ageing of the human corneal stroma: structural and biochemical changes. Biochim Biophys Acta (1992) 1.52
Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection (2004) 1.51
Serum susceptibility of Haemophilus somnus from bovine clinical cases and carriers. J Clin Microbiol (1985) 1.51
A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci U S A (1995) 1.43
Cresyl fast violet staining method for Campylobacter like organisms. J Clin Pathol (1987) 1.41
Diagnostic MR imaging features of craniocerebral Aspergillosis of sino-nasal origin in immunocompetent patients. Acta Neurochir (Wien) (2005) 1.41
Geographical incidence of oesophageal cancer in West Kenya. East Afr Med J (1966) 1.40
The anatomy of an OPTI: Part 2. The CORE system. Ohio Osteopathic Hospital Association. Ohio Association of Osteopathic Medical Directors. Ohio Osteopathic Association. J Am Osteopath Assoc (1997) 1.39
Epithelial neoplasms of the vermiform appendix (exclusive of carcinoid). II. Cystadenomas, papillary adenomas, and adenomatous polyps of the appendix. Cancer (1976) 1.34
Phylogenetic study of the species within the family Streptomycetaceae. Antonie Van Leeuwenhoek (2011) 1.34
Identification and preliminary characterization of protein-cysteine farnesyltransferase. Proc Natl Acad Sci U S A (1990) 1.33
Altered copper metabolism in cultured cells from human Menkes' syndrome and mottled mouse mutants. Biochem Genet (1980) 1.33
A disk assay for poly- -hydroxybutyrate. Anal Biochem (1973) 1.33
Effects of creatine supplementation on housekeeping genes in human skeletal muscle using real-time RT-PCR. Physiol Genomics (2003) 1.31
Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood (1998) 1.29
The incidence of cancer of the oesophagus in West Kenya. Br J Cancer (1969) 1.29
Diversion colitis in patients with myelopathy: clinical, endoscopic, and histopathological findings. J Spinal Cord Med (2000) 1.29
Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med J (2007) 1.27
Corynebacterium mooreparkense sp. nov. and Corynebacterium casei sp. nov., isolated from the surface of a smear-ripened cheese. Int J Syst Evol Microbiol (2001) 1.26
Rapid identification of species within the Mycobacterium tuberculosis complex by artificial neural network analysis of pyrolysis mass spectra. J Med Microbiol (1994) 1.25
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer (2004) 1.23
Identification of a gene cluster, czr, involved in cadmium and zinc resistance in Pseudomonas aeruginosa. Gene (1999) 1.21
Novel rhodococci and other mycolate actinomycetes from the deep sea. Antonie Van Leeuwenhoek (1999) 1.20
Reappraisal of esophagogastrectomy for esophageal malignancy. Am J Surg (1979) 1.18
The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev (2004) 1.17
Long term survival after intensive care. BMJ (1990) 1.17
STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene (2000) 1.16
Immunoelectron microscopic localisation of the OMP90 family on the outer membrane surface of Chlamydia psittaci. FEMS Microbiol Lett (1998) 1.15
Videokeratography database of normal human corneas. Br J Ophthalmol (1996) 1.15
Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans (2003) 1.15
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer (2005) 1.13
Evolution of VHL tumourigenesis in nerve root tissue. J Pathol (2006) 1.11
B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res (2000) 1.10
Epitopes in the interacting regions of beta-dystroglycan (PPxY motif) and dystrophin (WW domain). Biochim Biophys Acta (2001) 1.10
Hernia-sac cancer. Lancet (1969) 1.10
A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. Int J Tuberc Lung Dis (2003) 1.09
Characterisation of the urease-encoding gene complex of Yersinia enterocolitica. Gene (1994) 1.07
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma. Cancer Gene Ther (2011) 1.07
Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol Cell Endocrinol (2006) 1.05
Sports injuries in New Zealand. N Z Med J (1986) 1.05
Stop routine CD4 monitoring in HIV-infected patients with fully suppressed virus and CD4 >=350 cells/ml. Clin Infect Dis (2013) 1.05
Subclavian vein catheterization in the infant. J Pediatr Surg (1974) 1.05
C/EBPalpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia (2001) 1.05
Lifestyle and biologic contributors to proximal femur bone mineral density and hip axis length in two distinct ethnic groups of premenopausal women. Osteoporos Int (1999) 1.03
Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect? Int J Obes (Lond) (2008) 1.03
Biovariants of isolates of Pasteurella from domestic and wild ruminants. J Vet Diagn Invest (1998) 1.03
UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjects. Pflugers Arch (2002) 1.03
Inadvertent doping through supplement use by athletes: assessment and management of the risk in Australia. Int J Sport Nutr Exerc Metab (2001) 1.02
Reduction of Cr(VI) and bioaccumulation of chromium by gram positive and gram negative microorganisms not previously exposed to Cr-stress. Environ Technol (2002) 1.02
Thrombosis after central venous cannulation. Med J Aust (1976) 1.02
Bacterial interactions in bovine respiratory and reproductive infections. J Clin Microbiol (1985) 1.01
The public's response to the obesity epidemic in Australia: weight concerns and weight control practices of men and women. Public Health Nutr (2000) 1.01
Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. Br J Cancer (2005) 1.01
Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. Bioorg Med Chem Lett (2003) 0.99
Using quality indicators in anaesthesia: feeding back data to improve care. Br J Anaesth (2012) 0.99
Hydroxyapatite/metal composite coatings formed by electrocodeposition. J Biomed Mater Res (1996) 0.98
Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol (2012) 0.98
Promotion of hexagonal phase formation and lipid mixing by fatty acids with varying degrees of unsaturation. Chem Phys Lipids (1991) 0.98
Biosystematics and diversity amongst novel carboxydotrophic actinomycetes. Antonie Van Leeuwenhoek (1994) 0.98
Microbacterium gubbeenense sp. nov., from the surface of a smear-ripened cheese. Int J Syst Evol Microbiol (2001) 0.98
Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). Clin Cardiol (2001) 0.98
Resistant starch in the diet increases breath hydrogen and serum acetate in human subjects. Am J Clin Nutr (1995) 0.97
Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac J Trop Med (2013) 0.97
The Nocardia salmonicida clade, including descriptions of Nocardia cummidelens sp. nov., Nocardia fluminea sp. nov. and Nocardia soli sp. nov. Antonie Van Leeuwenhoek (2000) 0.96
Telomerase activity in a specific cell subset co-expressing integrinbeta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells. Oncogene (1998) 0.96
Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank. J Pak Med Assoc (2003) 0.96
Abortion in the dog due to Campylobacter species. Am J Vet Res (1984) 0.95
Infectious agents associated with neonatal calf disease in southwestern Idaho and eastern Oregon. J Am Vet Med Assoc (1982) 0.95
HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS (2011) 0.94
Classification and identification of rhodococci. Zentralbl Bakteriol (1990) 0.94
High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia (2004) 0.94
Use of DNA analysis of Pasteurella haemolytica biotype T isolates to monitor transmission in bighorn sheep (Ovis canadensis canadensis). J Clin Microbiol (1993) 0.94
The effect of mechanical strain on hyaluronan metabolism in embryonic fibrocartilage cells. Matrix Biol (1999) 0.94
The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis (2012) 0.93
Primary extramedullary esophageal plasmacytoma: First case report. Cancer (1976) 0.93
Lowering blood viscosity to overcome vascular resistance. Surg Gynecol Obstet (1980) 0.93
The iodide space in rabbit brain. J Physiol (1969) 0.93